NCT01396564View on ClinicalTrials.gov

Pioglitazone and Metformin in Diabetic Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

July 31, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

Metformin

850 mg of Metformin daily, increased to 1700 mg after 12 weeks, for the duration of the trial.

DRUG

Pioglitazone

15 mg of pioglitazone daily, increased to 60 mg after 12 weeks.

Trial Locations (1)

06720

"Endocrine Outpatient Clinic of the Hospital de Pediatria del CMN Siglo XXI", Mexico City

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT01396564 - Pioglitazone and Metformin in Diabetic Children | Biotech Hunter | Biotech Hunter